Sepsis causes: Difference between revisions
(→Causes) |
m (Bot: Removing from Primary care) |
||
(21 intermediate revisions by 8 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{| class="infobox" style="float: right;" | |||
| style="vertical-align: middle; padding: 5px;" align=center | [[File:Siren.gif|30px|link=Sepsis resident survival guide]] | |||
| style="vertical-align: middle; padding: 5px;" align=center | [[Sepsis resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | |||
|} | |||
{{Sepsis}} | {{Sepsis}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org] | |||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M. | |||
==Overview== | ==Overview== | ||
The process of [[infection]] by [[bacteria]] or [[fungi]] can result in systemic signs and symptoms that are variously described. In rough order of severity, these are [[bacteremia]] or [[fungemia]]; [[septicemia]]; [[sepsis]], severe sepsis or sepsis syndrome; septic shock; refractory septic shock; [[multiple organ dysfunction syndrome]], and [[death]]. The condition develops as a response to certain [[microbe|microbial]] molecules which trigger the production and release of cellular mediators, such as [[tumor necrosis factors]] (TNF); these act to stimulate immune response. | The process of [[infection]] by [[bacteria]] or [[fungi]] can result in systemic signs and symptoms that are variously described. In rough order of severity, these are [[bacteremia]] or [[fungemia]]; [[septicemia]]; [[sepsis]], severe sepsis or sepsis syndrome; septic shock; refractory septic shock; [[multiple organ dysfunction syndrome]], and [[death]]. The condition develops as a response to certain [[microbe|microbial]] molecules which trigger the production and release of cellular mediators, such as [[tumor necrosis factors]] (TNF); these act to stimulate immune response.<ref name="pmid24335434">{{cite journal |vauthors=Mayr FB, Yende S, Angus DC |title=Epidemiology of severe sepsis |journal=Virulence |volume=5 |issue=1 |pages=4–11 |year=2014 |pmid=24335434 |pmc=3916382 |doi=10.4161/viru.27372 |url=}}</ref> | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Sepsis is a life-threatening condition, if left untreated it results in death. | |||
===Common Causes=== | ===Common Causes=== | ||
Line 21: | Line 23: | ||
*In children, sepsis may accompany infection of the [[bone]] ([[osteomyelitis]]). | *In children, sepsis may accompany infection of the [[bone]] ([[osteomyelitis]]). | ||
*In hospitalized patients, common sites of infection include intravenous lines, [[surgical wounds]], surgical drains, and sites of skin breakdown known as [[bedsores]] ([[decubitus ulcers]]). | *In hospitalized patients, common sites of infection include intravenous lines, [[surgical wounds]], surgical drains, and sites of skin breakdown known as [[bedsores]] ([[decubitus ulcers]]). | ||
==Microorganisms== | |||
Common organisms responsible for sepsis includes:<ref name="pmid12851245">{{cite journal |vauthors=Annane D, Aegerter P, Jars-Guincestre MC, Guidet B |title=Current epidemiology of septic shock: the CUB-Réa Network |journal=Am. J. Respir. Crit. Care Med. |volume=168 |issue=2 |pages=165–72 |year=2003 |pmid=12851245 |doi=10.1164/rccm.2201087 |url=}}</ref><ref name="pmid17192537">{{cite journal |vauthors=Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C |title=An intervention to decrease catheter-related bloodstream infections in the ICU |journal=N. Engl. J. Med. |volume=355 |issue=26 |pages=2725–32 |year=2006 |pmid=17192537 |doi=10.1056/NEJMoa061115 |url=}}</ref> | |||
{| border="1" | |||
!colspan="1" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|Aerobic bacteria}} | |||
!colspan="1" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|Anaerobes bacteria}} | |||
!colspan="1" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|Fungal}} | |||
!colspan="1" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|Parasite}} | |||
|- | |||
|valign=top| | |||
* [[Enterococcus]] | |||
* [[Escherichia coli]] | |||
* [[Klebsiella pneumoniae]] | |||
* [[Pseudomonas aeruginosa]] | |||
* [[Staphylococcus aureus]] | |||
* [[Proteus]] | |||
|valign=top| | |||
* [[Bacteroides fragilis]] | |||
* [[Clostridium perfringens]] | |||
|valign=top| | |||
* [[Candida albicans]] | |||
* [[Candida tropicalis]] | |||
|valign=top| | |||
* [[Entamoeba histolytica]] | |||
|} | |||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
Line 37: | Line 64: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"|[[Aldesleukin]],[[Aprotinin]], [[Boceprevir]], [[Caspofungin acetate]], [[Crizotinib]], [[Cytarabine]], [[Dactinomycin]], [[Doxorubicin Hydrochloride]], [[Meropenem]], [[Mitomycin]], [[Pergolide]], [[Pramipexole]], [[Sipuleucel-T]], [[Sirolimus]], [[Tiagabine]], [[Tocilizumab]], [[Vedolizumab]] | |bgcolor="Beige"|[[Aldesleukin]],[[Aprotinin]], [[Boceprevir]], [[Caspofungin acetate]], [[Ceritinib]], [[Crizotinib]], [[Cytarabine]], [[Dactinomycin]], [[Doxorubicin Hydrochloride]], [[Felbamate]], [[Ixabepilone]], [[Meropenem]], [[Mitomycin]], [[Oxaprozin]], [[Pergolide]], [[Pralatrexate]], , [[Pramipexole]], [[Sargramostim]], [[Sipuleucel-T]], [[Sirolimus]], [[Strontium chloride]], [[Tiagabine]], [[Tocilizumab]], [[Vedolizumab]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 69: | Line 96: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"|[[Enterococcus]], [[Escherichia coli]], [[Klebsiella pneumoniae]], [[Pseudomonas aeruginosa]], [[Staphylococcus aureus]], [[Proteus]], | ||
[[Bacteroides fragilis]], [[Clostridium perfringens]], [[Candida albicans]], [[Candida tropicalis]], [[Entamoeba histolytica]] | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 134: | Line 162: | ||
===Causes in Alphabetical Order=== | ===Causes in Alphabetical Order=== | ||
{{Columns-list|3| | |||
*[[Anthrax]] | *[[Anthrax]] | ||
*[[Boceprevir]] | *[[Boceprevir]] | ||
Line 141: | Line 170: | ||
*[[Gangrene]] | *[[Gangrene]] | ||
*[[Gram negative bacteremia]] | *[[Gram negative bacteremia]] | ||
*[[Ixabepilone]] | |||
*[[Lemierre syndrome]] | *[[Lemierre syndrome]] | ||
*[[Melioidosis]] | *[[Melioidosis]] | ||
*[[Necrotizing enterocolitis]] | *[[Necrotizing enterocolitis]] | ||
*[[Neisseria meningiditis]] | *[[Neisseria meningiditis]] | ||
*[[Oxaprozin]] | |||
*[[Pergolide]] | *[[Pergolide]] | ||
*[[Peritonitis]] | *[[Peritonitis]] | ||
*[[Pralatrexate]], | |||
*[[Pseudomonas aeruginosa]] | *[[Pseudomonas aeruginosa]] | ||
*[[Sargramostim]] | |||
*[[Sipuleucel-T]] | *[[Sipuleucel-T]] | ||
*[[Tiagabine]] | *[[Tiagabine]] | ||
*[[Vibrio vulnificus]] | *[[Vibrio vulnificus]] | ||
}} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Intensive care medicine]] | [[Category:Intensive care medicine]] | ||
[[Category:Causes of death]] | [[Category:Causes of death]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[ | [[Category:Needs causes]] | ||
[[Category: | [[Category:Needs content]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] |
Latest revision as of 00:07, 30 July 2020
Resident Survival Guide |
Sepsis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sepsis causes On the Web |
American Roentgen Ray Society Images of Sepsis causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
The process of infection by bacteria or fungi can result in systemic signs and symptoms that are variously described. In rough order of severity, these are bacteremia or fungemia; septicemia; sepsis, severe sepsis or sepsis syndrome; septic shock; refractory septic shock; multiple organ dysfunction syndrome, and death. The condition develops as a response to certain microbial molecules which trigger the production and release of cellular mediators, such as tumor necrosis factors (TNF); these act to stimulate immune response.[1]
Causes
Life Threatening Causes
Sepsis is a life-threatening condition, if left untreated it results in death.
Common Causes
Sepsis is caused by a bacterial infection that can begin anywhere in the body. Common places where an infection might start include:
- The bowel (usually seen with peritonitis)
- The kidneys (upper urinary tract infection or pyelonephritis)
- The lining of the brain (meningitis)
- The liver or the gall bladder (cholecystitis)
- The lungs (bacterial pneumonia)
- The skin (cellulitis)
- In children, sepsis may accompany infection of the bone (osteomyelitis).
- In hospitalized patients, common sites of infection include intravenous lines, surgical wounds, surgical drains, and sites of skin breakdown known as bedsores (decubitus ulcers).
Microorganisms
Common organisms responsible for sepsis includes:[2][3]
Aerobic bacteria | Anaerobes bacteria | Fungal | Parasite |
---|---|---|---|
Causes by Organ System
Cardiovascular | Acute bacterial endocarditis, myocardial ring abscess, subacute bacterial endocarditis |
Chemical / poisoning | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect | Aldesleukin,Aprotinin, Boceprevir, Caspofungin acetate, Ceritinib, Crizotinib, Cytarabine, Dactinomycin, Doxorubicin Hydrochloride, Felbamate, Ixabepilone, Meropenem, Mitomycin, Oxaprozin, Pergolide, Pralatrexate, , Pramipexole, Sargramostim, Sipuleucel-T, Sirolimus, Strontium chloride, Tiagabine, Tocilizumab, Vedolizumab |
Ear Nose Throat | Bronchitis, otitis media, pharyngitis, sinusitis |
Endocrine | No underlying causes |
Environmental | No underlying causes |
Gastroenterologic | Abscess, Bicalutamide, esophagitis, gastritis, gastrointestinal bleeding, instrumentation, intestinal obstruction, pancreatitis, small intestine disorder |
Genetic | No underlying causes |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | Enterococcus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Proteus,
Bacteroides fragilis, Clostridium perfringens, Candida albicans, Candida tropicalis, Entamoeba histolytica |
Musculoskeletal / Ortho | Osteomyelitis, wound infections |
Neurologic | Acute bacterial meningitis |
Nutritional / Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic | No underlying causes |
Opthalmologic | No underlying causes |
Overdose / Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | Community-acquired pneumonia, empyema, lung abscess |
Renal / Electrolyte | Acute prostatitis/abscess, catheter-associated bacteriuria, cervicitis, chronic kidney disease, cystitis, instrumentation, intranephric abscess or perinephric abscess, pyelonephritis, renal calculi, urethritis, urinary tract obstruction, vaginitis |
Rheum / Immune / Allergy | No underlying causes |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | No underlying causes |
Causes in Alphabetical Order
References
- ↑ Mayr FB, Yende S, Angus DC (2014). "Epidemiology of severe sepsis". Virulence. 5 (1): 4–11. doi:10.4161/viru.27372. PMC 3916382. PMID 24335434.
- ↑ Annane D, Aegerter P, Jars-Guincestre MC, Guidet B (2003). "Current epidemiology of septic shock: the CUB-Réa Network". Am. J. Respir. Crit. Care Med. 168 (2): 165–72. doi:10.1164/rccm.2201087. PMID 12851245.
- ↑ Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C (2006). "An intervention to decrease catheter-related bloodstream infections in the ICU". N. Engl. J. Med. 355 (26): 2725–32. doi:10.1056/NEJMoa061115. PMID 17192537.